Improving the Quality of life: The Implication of Intrathecal Baclofen in patients with Protracted Spasticity

Keywords: Spasticity, Intrathecal Pump, Cerebral Palsy

Abstract

Spasticity is defined as a velocity-dependent increase in muscle tone. Clinically, it becomes more visible with a rapid stretching movement. The pathogenesis of this clinical entity involves upper motor neuron dysfunction. Patients could present with minor muscle stiffness to uncontrollable, painful muscle contractions. This increased tonicity of multiple muscle groups throughout the body significantly impacts mobility and leads to altered posturing, pressure ulcers, and even leads to continence problems. All of these considerably impede these patients' daily lives.

Downloads

Download data is not yet available.

References

1. Enslin J, Rohlwink UK, Figaji A. Management of Spasticity After Traumatic Brain Injury in Children. Front. Neurol. 2020; 11:126.
2. Ghai A, Garg N, Hooda S, Gupta T. Spasticity–Pathogenesis, prevention and treatment strategies. Saudi J Anaesth. 2013; 7(4):453.
3. Kappa-Opioid PD. In: Proceedings of the AAPM 2016 Annual Meeting: Pain Medicine; 08 February 2016; Oxford University Press. 2013; 17(2): 381–441. Available at: https://academic.oup.com/painmedicine/article/17/2/381/2460775
4. Díaz RC, Lotero MA, Escobar DC. Intrathecal Baclofen for the treatment of spasticity. Case report with thematic review. Colombian J Anesth. 2013; 41(3):229-235.
5. Abou Al-Shaar H, Alkhani A. Intrathecal baclofen therapy for spasticity: A compliance-based study to indicate effectiveness. Surg. Neurol. Int. 2016; 7(Suppl 19):S539.
Published
2020-12-01
How to Cite
Abbasi, Z., Anvekar, P. V., & Ahmed, M. F. (2020). Improving the Quality of life: The Implication of Intrathecal Baclofen in patients with Protracted Spasticity. International Journal of Endorsing Health Science Research (IJEHSR), 8(4), 171-172. https://doi.org/10.29052/IJEHSR.v8.i4.2020.171-172